$EDVA 4 SEC Filings

Filed On	Filing
15 Jun 2026	Form 4: Bondurant Michael Breen, Chief Operating Officer Granted 800,000 Stock Options (Right to Buy)
10 Jun 2026	Form 4: Fore Thomas Butler, Director Granted 500,000 Stock Options (Right to Buy)
10 Jun 2026	Form 4: Caple Frederick William, Director Granted 500,000 Stock Options (Right to Buy)
10 Jun 2026	Form 4: Francis Knuettel Ii, Director Granted 500,000 Stock Options (Right to Buy)
10 Jun 2026	Form 4: Cobb Brady James, Director Granted 925,000 Stock Options (Right to Buy)
10 Jun 2026	Form 4: Scott Martin P, Interim CFO Granted 700,000 Stock Options (Right to Buy)
31 Oct 2025	Form 4: Fore Thomas Butler, Director Granted 750,000 Warrants
20 Oct 2025	Form 4: Caple Frederick William, Director Granted 750,000 Warrants
20 Oct 2025	Form 4: Caple Frederick William, Director Received 1,875 shares as a grant or award · Granted 15,000 Stock Options (Right to Buy)
15 Oct 2025	Form 4: Nistico Robert, Director Granted 750,000 Warrants
15 Oct 2025	Form 4: Nistico Robert, Director Received 4,000 shares as a grant or award
15 Oct 2025	Form 4: Devereux William T, Chief Financial Officer Granted 15,000 Stock Options (Right to Buy)
15 Oct 2025	Form 4: Yorke Justin W, Director Granted 750,000 Warrants
14 Oct 2025	Form 4: Meissner William R., President and CMO Granted 750,000 Warrants
10 Oct 2025	Form 4: Devereux William T, Chief Financial Officer Granted 1,000,000 Warrants
06 May 2024	Form 4: Ivancsits Julius Paul, Chief Financial Officer Granted 750,000 Stock options
07 Mar 2024	Form 4: Paglia John Kenneth, Director Granted 600,000 Stock options
16 Oct 2023	Form 4: Dhalla Fatima, Interim CFO Granted 35,000 Stock options
03 Aug 2023	Form 4: Wall Ronald Charles, Chief Financial Officer Granted 222,000 Stock options
16 Jun 2023	Form 4: Nistico Robert, Director Bought 7,000 shares ($7.07K)

Comments